Media

Media

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY

January 2015

13

Historic decision from the European Commission grants 120 million women direct access to ellaOne® emergency contraceptive across the European Union.

December 2014

15

Ketoconazole HRA® Granted European Marketing Authorisation as an Orphan Drug for the Treatment of Endogenous Cushing’s Syndrome

Landmark recommendation from EMA paves the way for access without prescription to the ellaOne® morning-after pill across Europe in 2015.

November 2014

21

Landmark recommendation from EMA paves the way for access without prescription to the ellaOne® morning-after pill across Europe in 2015.

HRA Pharma Acquires a Novel Ovarian Cancer Immunotherapy from Pantarhei Bioscience

October 2014

27

HRA Pharma Acquires a Novel Ovarian Cancer Immunotherapy from Pantarhei Bioscience

September 2014

26

HRA Pharma Receives European CHMP Positive Opinion for Ketoconazole in the Treatment of Endogenous Cushing’s Syndrome

July 2014

24

Effect of weight on efficacy of Emergency Contraceptives...

July 2014

04

HRA Pharma wins the ‘Grand Prix des Entreprises de Croissance’

June 2014

03

HRA Pharma to Present at the Jefferies 2014 Global Healthcare Conference

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?